nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—hindbrain—brain cancer	0.0689	0.26	CbGeAlD
Degarelix—GNRHR—brainstem—brain cancer	0.0395	0.149	CbGeAlD
Degarelix—GNRHR—gonad—brain cancer	0.0293	0.11	CbGeAlD
Degarelix—GNRHR—pituitary gland—brain cancer	0.0285	0.108	CbGeAlD
Degarelix—GNRHR—endocrine gland—brain cancer	0.0221	0.0833	CbGeAlD
Degarelix—GNRHR—head—brain cancer	0.0218	0.0823	CbGeAlD
Degarelix—GNRHR—central nervous system—brain cancer	0.0199	0.0751	CbGeAlD
Degarelix—GNRHR—cerebellum—brain cancer	0.0195	0.0734	CbGeAlD
Degarelix—Febrile neutropenia—Procarbazine—brain cancer	0.0163	0.0222	CcSEcCtD
Degarelix—GNRHR—brain—brain cancer	0.0158	0.0596	CbGeAlD
Degarelix—Febrile neutropenia—Hydroxyurea—brain cancer	0.0126	0.0172	CcSEcCtD
Degarelix—Induration—Etoposide—brain cancer	0.0106	0.0145	CcSEcCtD
Degarelix—Nocturia—Procarbazine—brain cancer	0.0106	0.0144	CcSEcCtD
Degarelix—Febrile neutropenia—Carmustine—brain cancer	0.0102	0.0139	CcSEcCtD
Degarelix—Transaminases increased—Carmustine—brain cancer	0.0101	0.0138	CcSEcCtD
Degarelix—Febrile neutropenia—Temozolomide—brain cancer	0.00987	0.0134	CcSEcCtD
Degarelix—Gynaecomastia—Procarbazine—brain cancer	0.00879	0.012	CcSEcCtD
Degarelix—Renal failure—Lomustine—brain cancer	0.00851	0.0116	CcSEcCtD
Degarelix—Febrile neutropenia—Etoposide—brain cancer	0.0079	0.0108	CcSEcCtD
Degarelix—Abscess—Carmustine—brain cancer	0.00777	0.0106	CcSEcCtD
Degarelix—Alopecia—Lomustine—brain cancer	0.00687	0.00935	CcSEcCtD
Degarelix—Breast pain—Temozolomide—brain cancer	0.00681	0.00927	CcSEcCtD
Degarelix—Injection site reaction—Carmustine—brain cancer	0.00611	0.00832	CcSEcCtD
Degarelix—Musculoskeletal pain—Temozolomide—brain cancer	0.00601	0.00818	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00594	0.00809	CcSEcCtD
Degarelix—Influenza like illness—Temozolomide—brain cancer	0.00577	0.00785	CcSEcCtD
Degarelix—Pollakiuria—Procarbazine—brain cancer	0.00569	0.00775	CcSEcCtD
Degarelix—Gynaecomastia—Carmustine—brain cancer	0.0055	0.00749	CcSEcCtD
Degarelix—Pain—Carboplatin—brain cancer	0.0054	0.00735	CcSEcCtD
Degarelix—Mental disability—Carmustine—brain cancer	0.00533	0.00726	CcSEcCtD
Degarelix—Mental disability—Temozolomide—brain cancer	0.00515	0.00702	CcSEcCtD
Degarelix—Diabetes mellitus—Carmustine—brain cancer	0.00513	0.00698	CcSEcCtD
Degarelix—Swelling—Carmustine—brain cancer	0.00506	0.00688	CcSEcCtD
Degarelix—Body temperature increased—Carboplatin—brain cancer	0.00499	0.00679	CcSEcCtD
Degarelix—Breast disorder—Hydroxyurea—brain cancer	0.00499	0.00679	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00496	0.00675	CcSEcCtD
Degarelix—Inflammation—Etoposide—brain cancer	0.0049	0.00667	CcSEcCtD
Degarelix—Decreased appetite—Lomustine—brain cancer	0.0048	0.00653	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Etoposide—brain cancer	0.00475	0.00647	CcSEcCtD
Degarelix—Hot flush—Temozolomide—brain cancer	0.00461	0.00627	CcSEcCtD
Degarelix—Menopausal symptoms—Temozolomide—brain cancer	0.00457	0.00622	CcSEcCtD
Degarelix—Dysuria—Hydroxyurea—brain cancer	0.00446	0.00607	CcSEcCtD
Degarelix—Chills—Procarbazine—brain cancer	0.00443	0.00603	CcSEcCtD
Degarelix—Arrhythmia—Procarbazine—brain cancer	0.00441	0.006	CcSEcCtD
Degarelix—Body temperature increased—Lomustine—brain cancer	0.00436	0.00594	CcSEcCtD
Degarelix—Alopecia—Procarbazine—brain cancer	0.00436	0.00593	CcSEcCtD
Degarelix—Weight increased—Hydroxyurea—brain cancer	0.00434	0.00591	CcSEcCtD
Degarelix—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00402	0.00548	CcSEcCtD
Degarelix—Anaemia—Procarbazine—brain cancer	0.00397	0.0054	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00397	0.0054	CcSEcCtD
Degarelix—Muscular weakness—Carmustine—brain cancer	0.00394	0.00536	CcSEcCtD
Degarelix—Swelling—Etoposide—brain cancer	0.00391	0.00532	CcSEcCtD
Degarelix—Breast disorder—Temozolomide—brain cancer	0.0039	0.0053	CcSEcCtD
Degarelix—Muscular weakness—Temozolomide—brain cancer	0.0038	0.00518	CcSEcCtD
Degarelix—Hypertension—Procarbazine—brain cancer	0.00371	0.00505	CcSEcCtD
Degarelix—Arthralgia—Procarbazine—brain cancer	0.00366	0.00498	CcSEcCtD
Degarelix—Dry mouth—Procarbazine—brain cancer	0.00358	0.00487	CcSEcCtD
Degarelix—Cardiac failure—Etoposide—brain cancer	0.00354	0.00481	CcSEcCtD
Degarelix—Vomiting—Lomustine—brain cancer	0.00351	0.00478	CcSEcCtD
Degarelix—Dysuria—Temozolomide—brain cancer	0.00348	0.00474	CcSEcCtD
Degarelix—Hyperglycaemia—Carmustine—brain cancer	0.00348	0.00473	CcSEcCtD
Degarelix—Angiopathy—Hydroxyurea—brain cancer	0.00346	0.00472	CcSEcCtD
Degarelix—Pollakiuria—Temozolomide—brain cancer	0.00344	0.00469	CcSEcCtD
Degarelix—Erectile dysfunction—Temozolomide—brain cancer	0.00343	0.00467	CcSEcCtD
Degarelix—Depression—Carmustine—brain cancer	0.00343	0.00467	CcSEcCtD
Degarelix—Chills—Hydroxyurea—brain cancer	0.00343	0.00466	CcSEcCtD
Degarelix—Weight increased—Temozolomide—brain cancer	0.00339	0.00462	CcSEcCtD
Degarelix—Hyperhidrosis—Procarbazine—brain cancer	0.00339	0.00461	CcSEcCtD
Degarelix—Renal failure—Carmustine—brain cancer	0.00338	0.0046	CcSEcCtD
Degarelix—Alopecia—Hydroxyurea—brain cancer	0.00337	0.00459	CcSEcCtD
Degarelix—Weight decreased—Temozolomide—brain cancer	0.00337	0.00459	CcSEcCtD
Degarelix—Hyperglycaemia—Temozolomide—brain cancer	0.00336	0.00458	CcSEcCtD
Degarelix—Urinary tract infection—Carmustine—brain cancer	0.00334	0.00455	CcSEcCtD
Degarelix—Erythema—Hydroxyurea—brain cancer	0.00332	0.00452	CcSEcCtD
Degarelix—Depression—Temozolomide—brain cancer	0.00331	0.00451	CcSEcCtD
Degarelix—Nausea—Lomustine—brain cancer	0.00328	0.00446	CcSEcCtD
Degarelix—Hypotension—Procarbazine—brain cancer	0.00328	0.00446	CcSEcCtD
Degarelix—Urinary tract infection—Temozolomide—brain cancer	0.00323	0.0044	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00319	0.00435	CcSEcCtD
Degarelix—Insomnia—Procarbazine—brain cancer	0.00317	0.00432	CcSEcCtD
Degarelix—Hepatobiliary disease—Temozolomide—brain cancer	0.00314	0.00428	CcSEcCtD
Degarelix—Ill-defined disorder—Hydroxyurea—brain cancer	0.00308	0.0042	CcSEcCtD
Degarelix—Anaemia—Hydroxyurea—brain cancer	0.00307	0.00418	CcSEcCtD
Degarelix—Hypoaesthesia—Carmustine—brain cancer	0.00307	0.00418	CcSEcCtD
Degarelix—Decreased appetite—Procarbazine—brain cancer	0.00305	0.00415	CcSEcCtD
Degarelix—Oedema peripheral—Carmustine—brain cancer	0.00304	0.00414	CcSEcCtD
Degarelix—Fatigue—Procarbazine—brain cancer	0.00302	0.00411	CcSEcCtD
Degarelix—Malaise—Hydroxyurea—brain cancer	0.003	0.00408	CcSEcCtD
Degarelix—Pain—Procarbazine—brain cancer	0.003	0.00408	CcSEcCtD
Degarelix—Constipation—Procarbazine—brain cancer	0.003	0.00408	CcSEcCtD
Degarelix—Hypoaesthesia—Temozolomide—brain cancer	0.00297	0.00404	CcSEcCtD
Degarelix—Urinary tract disorder—Temozolomide—brain cancer	0.00295	0.00401	CcSEcCtD
Degarelix—Oedema peripheral—Temozolomide—brain cancer	0.00294	0.004	CcSEcCtD
Degarelix—Urethral disorder—Temozolomide—brain cancer	0.00292	0.00398	CcSEcCtD
Degarelix—Feeling abnormal—Procarbazine—brain cancer	0.00289	0.00393	CcSEcCtD
Degarelix—Eye disorder—Carmustine—brain cancer	0.00288	0.00393	CcSEcCtD
Degarelix—Gastrointestinal pain—Procarbazine—brain cancer	0.00287	0.0039	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00281	0.00383	CcSEcCtD
Degarelix—Discomfort—Hydroxyurea—brain cancer	0.0028	0.00381	CcSEcCtD
Degarelix—Eye disorder—Temozolomide—brain cancer	0.00279	0.00379	CcSEcCtD
Degarelix—Urticaria—Procarbazine—brain cancer	0.00278	0.00379	CcSEcCtD
Degarelix—Abdominal pain—Procarbazine—brain cancer	0.00277	0.00377	CcSEcCtD
Degarelix—Body temperature increased—Procarbazine—brain cancer	0.00277	0.00377	CcSEcCtD
Degarelix—Cardiac disorder—Temozolomide—brain cancer	0.00277	0.00377	CcSEcCtD
Degarelix—Arrhythmia—Carmustine—brain cancer	0.00276	0.00375	CcSEcCtD
Degarelix—Alopecia—Carmustine—brain cancer	0.00273	0.00371	CcSEcCtD
Degarelix—Angiopathy—Temozolomide—brain cancer	0.00271	0.00368	CcSEcCtD
Degarelix—Mental disorder—Carmustine—brain cancer	0.0027	0.00368	CcSEcCtD
Degarelix—Immune system disorder—Temozolomide—brain cancer	0.00269	0.00367	CcSEcCtD
Degarelix—Mediastinal disorder—Temozolomide—brain cancer	0.00269	0.00366	CcSEcCtD
Degarelix—Erythema—Carmustine—brain cancer	0.00269	0.00366	CcSEcCtD
Degarelix—Malnutrition—Carmustine—brain cancer	0.00269	0.00366	CcSEcCtD
Degarelix—Chills—Temozolomide—brain cancer	0.00268	0.00364	CcSEcCtD
Degarelix—Nervous system disorder—Hydroxyurea—brain cancer	0.00266	0.00362	CcSEcCtD
Degarelix—Alopecia—Temozolomide—brain cancer	0.00264	0.00359	CcSEcCtD
Degarelix—Skin disorder—Hydroxyurea—brain cancer	0.00263	0.00359	CcSEcCtD
Degarelix—Acute coronary syndrome—Etoposide—brain cancer	0.00262	0.00357	CcSEcCtD
Degarelix—Renal failure—Etoposide—brain cancer	0.00261	0.00356	CcSEcCtD
Degarelix—Mental disorder—Temozolomide—brain cancer	0.00261	0.00356	CcSEcCtD
Degarelix—Myocardial infarction—Etoposide—brain cancer	0.00261	0.00355	CcSEcCtD
Degarelix—Back pain—Carmustine—brain cancer	0.0026	0.00354	CcSEcCtD
Degarelix—Malnutrition—Temozolomide—brain cancer	0.0026	0.00353	CcSEcCtD
Degarelix—Erythema—Temozolomide—brain cancer	0.0026	0.00353	CcSEcCtD
Degarelix—Hypersensitivity—Procarbazine—brain cancer	0.00258	0.00352	CcSEcCtD
Degarelix—Vision blurred—Carmustine—brain cancer	0.00253	0.00345	CcSEcCtD
Degarelix—Asthenia—Procarbazine—brain cancer	0.00251	0.00342	CcSEcCtD
Degarelix—Hepatobiliary disease—Etoposide—brain cancer	0.00251	0.00342	CcSEcCtD
Degarelix—Back pain—Temozolomide—brain cancer	0.00251	0.00342	CcSEcCtD
Degarelix—Anaemia—Carmustine—brain cancer	0.00248	0.00338	CcSEcCtD
Degarelix—Pruritus—Procarbazine—brain cancer	0.00248	0.00338	CcSEcCtD
Degarelix—Vision blurred—Temozolomide—brain cancer	0.00245	0.00333	CcSEcCtD
Degarelix—Dyspnoea—Hydroxyurea—brain cancer	0.00242	0.00329	CcSEcCtD
Degarelix—Ill-defined disorder—Temozolomide—brain cancer	0.00241	0.00328	CcSEcCtD
Degarelix—Anaemia—Temozolomide—brain cancer	0.0024	0.00327	CcSEcCtD
Degarelix—Diarrhoea—Procarbazine—brain cancer	0.0024	0.00326	CcSEcCtD
Degarelix—Hypoaesthesia—Etoposide—brain cancer	0.00237	0.00323	CcSEcCtD
Degarelix—Decreased appetite—Hydroxyurea—brain cancer	0.00236	0.00321	CcSEcCtD
Degarelix—Urinary tract disorder—Etoposide—brain cancer	0.00236	0.00321	CcSEcCtD
Degarelix—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00234	0.00319	CcSEcCtD
Degarelix—Malaise—Temozolomide—brain cancer	0.00234	0.00319	CcSEcCtD
Degarelix—Urethral disorder—Etoposide—brain cancer	0.00234	0.00318	CcSEcCtD
Degarelix—Fatigue—Hydroxyurea—brain cancer	0.00234	0.00318	CcSEcCtD
Degarelix—Hypertension—Carmustine—brain cancer	0.00232	0.00316	CcSEcCtD
Degarelix—Pain—Hydroxyurea—brain cancer	0.00232	0.00316	CcSEcCtD
Degarelix—Constipation—Hydroxyurea—brain cancer	0.00232	0.00316	CcSEcCtD
Degarelix—Dizziness—Procarbazine—brain cancer	0.00232	0.00315	CcSEcCtD
Degarelix—Palpitations—Temozolomide—brain cancer	0.00229	0.00312	CcSEcCtD
Degarelix—Hypertension—Temozolomide—brain cancer	0.00224	0.00305	CcSEcCtD
Degarelix—Feeling abnormal—Hydroxyurea—brain cancer	0.00224	0.00304	CcSEcCtD
Degarelix—Eye disorder—Etoposide—brain cancer	0.00223	0.00304	CcSEcCtD
Degarelix—Vomiting—Procarbazine—brain cancer	0.00223	0.00303	CcSEcCtD
Degarelix—Cardiac disorder—Etoposide—brain cancer	0.00222	0.00302	CcSEcCtD
Degarelix—Arthralgia—Temozolomide—brain cancer	0.00221	0.00301	CcSEcCtD
Degarelix—Rash—Procarbazine—brain cancer	0.00221	0.00301	CcSEcCtD
Degarelix—Dermatitis—Procarbazine—brain cancer	0.00221	0.00301	CcSEcCtD
Degarelix—Headache—Procarbazine—brain cancer	0.0022	0.00299	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.0022	0.00299	CcSEcCtD
Degarelix—Discomfort—Temozolomide—brain cancer	0.00218	0.00297	CcSEcCtD
Degarelix—Angiopathy—Etoposide—brain cancer	0.00217	0.00295	CcSEcCtD
Degarelix—Dry mouth—Temozolomide—brain cancer	0.00216	0.00294	CcSEcCtD
Degarelix—Immune system disorder—Etoposide—brain cancer	0.00216	0.00293	CcSEcCtD
Degarelix—Mediastinal disorder—Etoposide—brain cancer	0.00215	0.00293	CcSEcCtD
Degarelix—Body temperature increased—Hydroxyurea—brain cancer	0.00214	0.00292	CcSEcCtD
Degarelix—Chills—Etoposide—brain cancer	0.00214	0.00292	CcSEcCtD
Degarelix—Anaphylactic shock—Temozolomide—brain cancer	0.00212	0.00288	CcSEcCtD
Degarelix—Alopecia—Etoposide—brain cancer	0.00211	0.00287	CcSEcCtD
Degarelix—Nausea—Procarbazine—brain cancer	0.00208	0.00283	CcSEcCtD
Degarelix—Nervous system disorder—Temozolomide—brain cancer	0.00208	0.00283	CcSEcCtD
Degarelix—Skin disorder—Temozolomide—brain cancer	0.00206	0.0028	CcSEcCtD
Degarelix—Hypotension—Carmustine—brain cancer	0.00205	0.00279	CcSEcCtD
Degarelix—Hyperhidrosis—Temozolomide—brain cancer	0.00205	0.00279	CcSEcCtD
Degarelix—Back pain—Etoposide—brain cancer	0.00201	0.00274	CcSEcCtD
Degarelix—Hypersensitivity—Hydroxyurea—brain cancer	0.002	0.00272	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Carmustine—brain cancer	0.002	0.00272	CcSEcCtD
Degarelix—Muscle spasms—Etoposide—brain cancer	0.002	0.00272	CcSEcCtD
Degarelix—Insomnia—Carmustine—brain cancer	0.00198	0.0027	CcSEcCtD
Degarelix—Dyspnoea—Carmustine—brain cancer	0.00196	0.00266	CcSEcCtD
Degarelix—Asthenia—Hydroxyurea—brain cancer	0.00195	0.00265	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00193	0.00263	CcSEcCtD
Degarelix—Ill-defined disorder—Etoposide—brain cancer	0.00193	0.00262	CcSEcCtD
Degarelix—Anaemia—Etoposide—brain cancer	0.00192	0.00261	CcSEcCtD
Degarelix—Insomnia—Temozolomide—brain cancer	0.00192	0.00261	CcSEcCtD
Degarelix—Decreased appetite—Carmustine—brain cancer	0.00191	0.00259	CcSEcCtD
Degarelix—Gastrointestinal disorder—Carmustine—brain cancer	0.00189	0.00258	CcSEcCtD
Degarelix—Dyspnoea—Temozolomide—brain cancer	0.00189	0.00257	CcSEcCtD
Degarelix—Constipation—Carmustine—brain cancer	0.00188	0.00255	CcSEcCtD
Degarelix—Pain—Carmustine—brain cancer	0.00188	0.00255	CcSEcCtD
Degarelix—Malaise—Etoposide—brain cancer	0.00187	0.00255	CcSEcCtD
Degarelix—Diarrhoea—Hydroxyurea—brain cancer	0.00186	0.00253	CcSEcCtD
Degarelix—Decreased appetite—Temozolomide—brain cancer	0.00184	0.00251	CcSEcCtD
Degarelix—Gastrointestinal disorder—Temozolomide—brain cancer	0.00183	0.00249	CcSEcCtD
Degarelix—Fatigue—Temozolomide—brain cancer	0.00183	0.00249	CcSEcCtD
Degarelix—Constipation—Temozolomide—brain cancer	0.00181	0.00247	CcSEcCtD
Degarelix—Pain—Temozolomide—brain cancer	0.00181	0.00247	CcSEcCtD
Degarelix—Feeling abnormal—Carmustine—brain cancer	0.00181	0.00246	CcSEcCtD
Degarelix—Hypertension—Etoposide—brain cancer	0.00179	0.00244	CcSEcCtD
Degarelix—Dizziness—Hydroxyurea—brain cancer	0.00179	0.00244	CcSEcCtD
Degarelix—Gastrointestinal pain—Carmustine—brain cancer	0.00179	0.00244	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00176	0.00239	CcSEcCtD
Degarelix—Discomfort—Etoposide—brain cancer	0.00175	0.00238	CcSEcCtD
Degarelix—Feeling abnormal—Temozolomide—brain cancer	0.00175	0.00238	CcSEcCtD
Degarelix—Abdominal pain—Carmustine—brain cancer	0.00173	0.00236	CcSEcCtD
Degarelix—Body temperature increased—Carmustine—brain cancer	0.00173	0.00236	CcSEcCtD
Degarelix—Gastrointestinal pain—Temozolomide—brain cancer	0.00173	0.00236	CcSEcCtD
Degarelix—Vomiting—Hydroxyurea—brain cancer	0.00172	0.00235	CcSEcCtD
Degarelix—Rash—Hydroxyurea—brain cancer	0.00171	0.00233	CcSEcCtD
Degarelix—Dermatitis—Hydroxyurea—brain cancer	0.00171	0.00233	CcSEcCtD
Degarelix—Headache—Hydroxyurea—brain cancer	0.0017	0.00231	CcSEcCtD
Degarelix—Anaphylactic shock—Etoposide—brain cancer	0.0017	0.00231	CcSEcCtD
Degarelix—Urticaria—Temozolomide—brain cancer	0.00168	0.00229	CcSEcCtD
Degarelix—Abdominal pain—Temozolomide—brain cancer	0.00168	0.00228	CcSEcCtD
Degarelix—Body temperature increased—Temozolomide—brain cancer	0.00168	0.00228	CcSEcCtD
Degarelix—Skin disorder—Etoposide—brain cancer	0.00165	0.00224	CcSEcCtD
Degarelix—Hyperhidrosis—Etoposide—brain cancer	0.00164	0.00223	CcSEcCtD
Degarelix—Hypersensitivity—Carmustine—brain cancer	0.00162	0.0022	CcSEcCtD
Degarelix—Nausea—Hydroxyurea—brain cancer	0.00161	0.00219	CcSEcCtD
Degarelix—Hypotension—Etoposide—brain cancer	0.00158	0.00216	CcSEcCtD
Degarelix—Asthenia—Carmustine—brain cancer	0.00157	0.00214	CcSEcCtD
Degarelix—Hypersensitivity—Temozolomide—brain cancer	0.00156	0.00213	CcSEcCtD
Degarelix—Asthenia—Temozolomide—brain cancer	0.00152	0.00207	CcSEcCtD
Degarelix—Dyspnoea—Etoposide—brain cancer	0.00151	0.00206	CcSEcCtD
Degarelix—Diarrhoea—Carmustine—brain cancer	0.0015	0.00204	CcSEcCtD
Degarelix—Pruritus—Temozolomide—brain cancer	0.0015	0.00204	CcSEcCtD
Degarelix—Decreased appetite—Etoposide—brain cancer	0.00147	0.00201	CcSEcCtD
Degarelix—Gastrointestinal disorder—Etoposide—brain cancer	0.00146	0.00199	CcSEcCtD
Degarelix—Fatigue—Etoposide—brain cancer	0.00146	0.00199	CcSEcCtD
Degarelix—Dizziness—Carmustine—brain cancer	0.00145	0.00197	CcSEcCtD
Degarelix—Constipation—Etoposide—brain cancer	0.00145	0.00197	CcSEcCtD
Degarelix—Pain—Etoposide—brain cancer	0.00145	0.00197	CcSEcCtD
Degarelix—Diarrhoea—Temozolomide—brain cancer	0.00145	0.00197	CcSEcCtD
Degarelix—Dizziness—Temozolomide—brain cancer	0.0014	0.00191	CcSEcCtD
Degarelix—Feeling abnormal—Etoposide—brain cancer	0.0014	0.0019	CcSEcCtD
Degarelix—Vomiting—Carmustine—brain cancer	0.00139	0.0019	CcSEcCtD
Degarelix—Gastrointestinal pain—Etoposide—brain cancer	0.00139	0.00189	CcSEcCtD
Degarelix—Rash—Carmustine—brain cancer	0.00138	0.00188	CcSEcCtD
Degarelix—Dermatitis—Carmustine—brain cancer	0.00138	0.00188	CcSEcCtD
Degarelix—Headache—Carmustine—brain cancer	0.00137	0.00187	CcSEcCtD
Degarelix—Vomiting—Temozolomide—brain cancer	0.00135	0.00183	CcSEcCtD
Degarelix—Urticaria—Etoposide—brain cancer	0.00135	0.00183	CcSEcCtD
Degarelix—Abdominal pain—Etoposide—brain cancer	0.00134	0.00182	CcSEcCtD
Degarelix—Body temperature increased—Etoposide—brain cancer	0.00134	0.00182	CcSEcCtD
Degarelix—Rash—Temozolomide—brain cancer	0.00134	0.00182	CcSEcCtD
Degarelix—Dermatitis—Temozolomide—brain cancer	0.00133	0.00182	CcSEcCtD
Degarelix—Headache—Temozolomide—brain cancer	0.00133	0.00181	CcSEcCtD
Degarelix—Nausea—Carmustine—brain cancer	0.0013	0.00177	CcSEcCtD
Degarelix—Nausea—Temozolomide—brain cancer	0.00126	0.00171	CcSEcCtD
Degarelix—Hypersensitivity—Etoposide—brain cancer	0.00125	0.0017	CcSEcCtD
Degarelix—Asthenia—Etoposide—brain cancer	0.00122	0.00166	CcSEcCtD
Degarelix—Pruritus—Etoposide—brain cancer	0.0012	0.00163	CcSEcCtD
Degarelix—Diarrhoea—Etoposide—brain cancer	0.00116	0.00158	CcSEcCtD
Degarelix—Dizziness—Etoposide—brain cancer	0.00112	0.00153	CcSEcCtD
Degarelix—Vomiting—Etoposide—brain cancer	0.00108	0.00147	CcSEcCtD
Degarelix—Rash—Etoposide—brain cancer	0.00107	0.00146	CcSEcCtD
Degarelix—Dermatitis—Etoposide—brain cancer	0.00107	0.00145	CcSEcCtD
Degarelix—Headache—Etoposide—brain cancer	0.00106	0.00145	CcSEcCtD
Degarelix—Nausea—Etoposide—brain cancer	0.00101	0.00137	CcSEcCtD
